Phase 2 Naval Spray for COVID

Early data from a Phase 2 trial in the UK shows that a nitric oxide nasal spray can decrease viral load in COVID-19 positive patients by 95% in one day and 99% over three days. This has the potential to be a breakthrough in managing COVID-19 infections. Higher viral load is associated with worse clinical outcomes and greater transmission of the virus. Nitric oxide is a natural substance produced by the body with a safety profile that has been known for decades.

Leave a reply